ANTH perpetual futures
Go long or short ANTH with up to 10x leverage and isolated margin on Hyperliquid, funded straight from your pump wallet.
- Mark
- $91.62
- 24h change
- −8.83%
- Leverage
- 10x
- Funding
- 0.0298% (261.06% APR)
- Funding interval
- Every hour
- Next funding
- 24h volume
- $1.27M
- Open interest
- $147K
- Min order
- $10.00
- Provider
- Hyperliquid
About
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
What are the risks?
If the price moves too far against you, your position gets liquidated and you lose the money you put in. Higher leverage means a smaller move can wipe you out.
ANTH
10xPARAWe value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
